The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan

Chyi-Liang Chen; Pin-Chun Hou; Yun-Ting Wang; Hao-Yuan Lee; Ying-Li Zhou; Ting-Shu Wu; Rajendra-Prasad Janapatla; Chien-Chang Yang

doi:10.3855/jidc.11524

The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan

Authors

Chyi-Liang Chen Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Pin-Chun Hou Department of Medicine, Chang Gung University, College of Medicine, Taoyuan, Taiwan
Yun-Ting Wang Department of Medicine, Chang Gung University, College of Medicine, Taoyuan, Taiwan
Hao-Yuan Lee Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Ying-Li Zhou Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung Memorial Hospital, Taoyuan
Ting-Shu Wu Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Rajendra-Prasad Janapatla Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Chien-Chang Yang Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan

DOI:

https://doi.org/10.3855/jidc.11524

Keywords:

Klebsiella pneumoniae, bloodstream infection, serotype, multidrug resistance, mortality

Abstract

Introduction: Klebsiella pneumoniae, a common hospital- and community-acquired pathogen, is notorious for multidrug resistance. This study aimed to better understand the correlation of clinical presentation and microbiological characteristics of the isolates causing bloodstream infections (BSIs) in Taiwan.

Methodology: We retrospectively collected 150 isolates derived from K. pneumoniae bacteremia patients in Taiwan in both 2014 and 2016. Clinical data, bacterial serotyping and drug susceptibility tests were comparatively analyzed.

Results: Demographic data showed that diabetes mellitus (DM) was the most common underlying disease (44.0%). The overall 30-day mortality rate was 19.3%, and higher mortality was found in patients with malignancy than others (P = 0.023). Serotype distribution was diverse. The major isolates belonged to non-PCR-typeable serotypes (58.7%) associated with hospital-acquired infections (P = 0.007) and in non-DM patients (P < 0.001), while K2 and K20 significantly caused infections and in DM patients (P = 0.046 and P = 0.006, respectively); however, only K2 showed more community-acquired infection (P = 0.022) than other typeable serotypes. Resistance to antibiotics in clinical isolates in the year 2016 was > 24%, including cefazolin (54%), ampicillin-sulbactam (25%) and cefuroxime (25%). Susceptibility to gentamicin, flomoxef, and tigecycline reduced between the two time periods (2014 and 2016). However, the isolates remained highly susceptible to amikacin and ertapenem (> 95%).

Conclusions: Patients with cancer had a higher 30-day mortality rate than others. Amikacin and ertapenem are the drugs of choice for the treatment of multidrug-resistant K. pneumoniae BSIs in Taiwan.

Downloads

Published

2020-04-30

How to Cite

Chen C-L, Hou P-C, Wang Y-T, Lee H-Y, Zhou Y-L, Wu T-S, Janapatla R-P, Yang C-C (2020) The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan. J Infect Dev Ctries 14:373–379. doi: 10.3855/jidc.11524

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 14 No. 04: April 2020

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).